In order to further explore the global molecular changes in PTEN-deficient and trastuzumab resistant breast cancer cells, gene set enrichment analysis (GSEA) was performed on the differentially expressed genes (Figure 1D). This evidence concerns the gene PTEN and breast carcinoma.